Di Yi Cai Jing·2025-05-11 11:28Group 1 - The public's awareness of diabetes and obesity is insufficient, leading to delayed diagnosis and treatment, which can result in severe complications and a heavy burden on patients and society [6][7][8] - May 11 is "World Obesity Day," marking a significant shift in the recognition and treatment of obesity, from national policies to new drug development and outpatient services [5][6] - Healthy lifestyles and exercise are important for preventing and addressing obesity, but experts indicate that obesity cannot be resolved solely through "eating less and moving more" [6][7] Group 2 - The "Obesity Diagnosis and Treatment Guidelines (2024 Edition)" clarify that the causes of obesity include genetic, lifestyle, disease, medication, environmental, and social factors [4] - The emergence of GLP-1 receptor agonists from companies like Novo Nordisk and Eli Lilly has transformed the treatment landscape for obesity, with new guidelines expected to be finalized by August or September 2025 [5][6] Group 3 - In China, approximately 180 million adults suffer from obesity, with the prevalence continuing to rise, yet public awareness remains low [6][7] - A survey revealed that only 16% of obese patients have used weight-loss medications, and a mere 11% sought medical advice, with many believing obesity is not a medical issue [6][7] Group 4 - Obesity is recognized as an endocrine metabolic disease, and without systematic intervention, the risks associated with the disease will accumulate and worsen over time [7][8] - Patients with obesity often have comorbidities such as diabetes, hypertension, and fatty liver, and early intervention through weight management can alleviate or even reverse these complications [9][10] Group 5 - Specialized weight management clinics are emerging, promoting proactive medical help and early screening for chronic disease risks [11][12] - Individualized treatment plans are essential for obesity management, incorporating medication, surgery, and lifestyle adjustments based on the patient's specific situation [12][10] Group 6 - Digital health platforms are being integrated into obesity management, with companies like JD.com and Tencent collaborating with Novo Nordisk to create a comprehensive digital obesity prevention and management system [13][14] - Novo Nordisk's "Novo Care" digital patient service platform aims to enhance treatment adherence and empower patients in long-term self-management of their conditions [14]